Efficacy and safety of endoscopic ultrasonography-guided embolization of gastric varices
Not Applicable
- Conditions
- gastric varices
- Registration Number
- JPRN-UMIN000051450
- Lead Sponsor
- agoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not agree to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication of gastric varices.
- Secondary Outcome Measures
Name Time Method Time required for the procedure. Incidence of adverse events such as postoperative bleeding, fever, and abdominal pain. Recurrence and rebleeding rates of esophagogastric varices. Mortality and liver transplantation rates.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are targeted by endoscopic ultrasonography-guided embolization in gastric varices?
How does EUS-guided embolization compare to endoscopic variceal ligation for gastric varices in terms of efficacy and safety?
Which biomarkers correlate with successful EUS-guided embolization outcomes in patients with portal hypertension-related gastric varices?
What are the most common adverse events associated with EUS-guided embolization for gastric varices and their management protocols?
Are there combination therapies involving EUS-guided embolization and pharmacological agents like octreotide for gastric varices management?